-
1
-
-
44049108744
-
Toward an AIDS vaccine
-
Walker B.D., and Burton D.R. Toward an AIDS vaccine. Science 320 May (5877) (2008) 760-764
-
(2008)
Science
, vol.320
, Issue.May 5877
, pp. 760-764
-
-
Walker, B.D.1
Burton, D.R.2
-
2
-
-
38949170716
-
Prospects of HIV Env modification as an approach to HIV vaccine design
-
Hu S.L., and Stamatatos L. Prospects of HIV Env modification as an approach to HIV vaccine design. Curr HIV Res 5 November (6) (2007) 507-513
-
(2007)
Curr HIV Res
, vol.5
, Issue.November 6
, pp. 507-513
-
-
Hu, S.L.1
Stamatatos, L.2
-
3
-
-
33144486096
-
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
-
Moore P.L., Crooks E.T., Porter L., Zhu P., Cayanan C.S., Grise H., et al. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J Virol 80 March (5) (2006) 2515-2528
-
(2006)
J Virol
, vol.80
, Issue.March 5
, pp. 2515-2528
-
-
Moore, P.L.1
Crooks, E.T.2
Porter, L.3
Zhu, P.4
Cayanan, C.S.5
Grise, H.6
-
4
-
-
34347256384
-
Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets
-
Phogat S., Wyatt R.T., and Karlsson Hedestam G.B. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets. J Intern Med 262 July (1) (2007) 26-43
-
(2007)
J Intern Med
, vol.262
, Issue.July 1
, pp. 26-43
-
-
Phogat, S.1
Wyatt, R.T.2
Karlsson Hedestam, G.B.3
-
5
-
-
0037213278
-
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
-
Poignard P., Moulard M., Golez E., Vivona V., Franti M., Venturini S., et al. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J Virol 77 January (1) (2003) 353-365
-
(2003)
J Virol
, vol.77
, Issue.January 1
, pp. 353-365
-
-
Poignard, P.1
Moulard, M.2
Golez, E.3
Vivona, V.4
Franti, M.5
Venturini, S.6
-
6
-
-
8644251891
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
-
Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 78 December (23) (2004) 13232-13252
-
(2004)
J Virol
, vol.78
, Issue.December 23
, pp. 13232-13252
-
-
Binley, J.M.1
Wrin, T.2
Korber, B.3
Zwick, M.B.4
Wang, M.5
Chappey, C.6
-
7
-
-
12444291017
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
-
Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300 June (5628) (2003) 2065-2071
-
(2003)
Science
, vol.300
, Issue.June 5628
, pp. 2065-2071
-
-
Calarese, D.A.1
Scanlan, C.N.2
Zwick, M.B.3
Deechongkit, S.4
Mimura, Y.5
Kunert, R.6
-
8
-
-
13844255333
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
-
Cardoso R.M., Zwick M.B., Stanfield R.L., Kunert R., Binley J.M., Katinger H., et al. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22 February (2) (2005) 163-173
-
(2005)
Immunity
, vol.22
, Issue.February 2
, pp. 163-173
-
-
Cardoso, R.M.1
Zwick, M.B.2
Stanfield, R.L.3
Kunert, R.4
Binley, J.M.5
Katinger, H.6
-
9
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67 November (11) (1993) 6642-6647
-
(1993)
J Virol
, vol.67
, Issue.November 11
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
-
10
-
-
4544379899
-
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
-
Ofek G., Tang M., Sambor A., Katinger H., Mascola J.R., Wyatt R., et al. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78 October (19) (2004) 10724-10737
-
(2004)
J Virol
, vol.78
, Issue.October 19
, pp. 10724-10737
-
-
Ofek, G.1
Tang, M.2
Sambor, A.3
Katinger, H.4
Mascola, J.R.5
Wyatt, R.6
-
11
-
-
0028291731
-
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
-
Roben P., Moore J.P., Thali M., Sodroski J., Barbas III C.F., and Burton D.R. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol 68 August (8) (1994) 4821-4828
-
(1994)
J Virol
, vol.68
, Issue.August 8
, pp. 4821-4828
-
-
Roben, P.1
Moore, J.P.2
Thali, M.3
Sodroski, J.4
Barbas III, C.F.5
Burton, D.R.6
-
12
-
-
0035000679
-
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region
-
Barnett S.W., Lu S., Srivastava I., Cherpelis S., Gettie A., Blanchard J., et al. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J Virol 75 June (12) (2001) 5526-5540
-
(2001)
J Virol
, vol.75
, Issue.June 12
, pp. 5526-5540
-
-
Barnett, S.W.1
Lu, S.2
Srivastava, I.3
Cherpelis, S.4
Gettie, A.5
Blanchard, J.6
-
13
-
-
21644445378
-
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
-
Beddows S., Schulke N., Kirschner M., Barnes K., Franti M., Michael E., et al. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 79 July (14) (2005) 8812-8827
-
(2005)
J Virol
, vol.79
, Issue.July 14
, pp. 8812-8827
-
-
Beddows, S.1
Schulke, N.2
Kirschner, M.3
Barnes, K.4
Franti, M.5
Michael, E.6
-
14
-
-
34548625655
-
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens
-
Derby N.R., Gray S., Wayner E., Campogan D., Vlahogiannis G., Kraft Z., et al. Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Virology 366 September (2) (2007) 433-445
-
(2007)
Virology
, vol.366
, Issue.September 2
, pp. 433-445
-
-
Derby, N.R.1
Gray, S.2
Wayner, E.3
Campogan, D.4
Vlahogiannis, G.5
Kraft, Z.6
-
15
-
-
33847293391
-
Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1
-
Dey A.K., David K.B., Klasse P.J., and Moore J.P. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 360 March (1) (2007) 199-208
-
(2007)
Virology
, vol.360
, Issue.March 1
, pp. 199-208
-
-
Dey, A.K.1
David, K.B.2
Klasse, P.J.3
Moore, J.P.4
-
16
-
-
0035168058
-
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140
-
Earl P.L., Sugiura W., Montefiori D.C., Broder C.C., Lee S.A., Wild C., et al. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. J Virol 75 January (2) (2001) 645-653
-
(2001)
J Virol
, vol.75
, Issue.January 2
, pp. 645-653
-
-
Earl, P.L.1
Sugiura, W.2
Montefiori, D.C.3
Broder, C.C.4
Lee, S.A.5
Wild, C.6
-
17
-
-
9944264023
-
Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins
-
Grundner C., Li Y., Louder M., Mascola J., Yang X., Sodroski J., et al. Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins. Virology 331 January (1) (2005) 33-46
-
(2005)
Virology
, vol.331
, Issue.January 1
, pp. 33-46
-
-
Grundner, C.1
Li, Y.2
Louder, M.3
Mascola, J.4
Yang, X.5
Sodroski, J.6
-
18
-
-
13144302861
-
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies
-
Kim M., Qiao Z.S., Montefiori D.C., Haynes B.F., Reinherz E.L., and Liao H.X. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res Hum Retroviruses 21 January (1) (2005) 58-67
-
(2005)
AIDS Res Hum Retroviruses
, vol.21
, Issue.January 1
, pp. 58-67
-
-
Kim, M.1
Qiao, Z.S.2
Montefiori, D.C.3
Haynes, B.F.4
Reinherz, E.L.5
Liao, H.X.6
-
19
-
-
31144451337
-
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
-
Li Y., Svehla K., Mathy N.L., Voss G., Mascola J.R., and Wyatt R. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol 80 February (3) (2006) 1414-1426
-
(2006)
J Virol
, vol.80
, Issue.February 3
, pp. 1414-1426
-
-
Li, Y.1
Svehla, K.2
Mathy, N.L.3
Voss, G.4
Mascola, J.R.5
Wyatt, R.6
-
20
-
-
0031906852
-
Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions
-
Lu S., Wyatt R., Richmond J.F., Mustafa F., Wang S., Weng J., et al. Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res Hum Retroviruses 14 January (2) (1998) 151-155
-
(1998)
AIDS Res Hum Retroviruses
, vol.14
, Issue.January 2
, pp. 151-155
-
-
Lu, S.1
Wyatt, R.2
Richmond, J.F.3
Mustafa, F.4
Wang, S.5
Weng, J.6
-
21
-
-
0025042354
-
Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies
-
Haigwood N.L., Shuster J.R., Moore G.K., Lee H., Skiles P.V., Higgins K.W., et al. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res Hum Retroviruses 6 July (7) (1990) 855-869
-
(1990)
AIDS Res Hum Retroviruses
, vol.6
, Issue.July 7
, pp. 855-869
-
-
Haigwood, N.L.1
Shuster, J.R.2
Moore, G.K.3
Lee, H.4
Skiles, P.V.5
Higgins, K.W.6
-
22
-
-
33947590277
-
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120
-
Beddows S., Franti M., Dey A.K., Kirschner M., Iyer S.P., Fisch D.C., et al. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. Virology 360 April (2) (2007) 329-340
-
(2007)
Virology
, vol.360
, Issue.April 2
, pp. 329-340
-
-
Beddows, S.1
Franti, M.2
Dey, A.K.3
Kirschner, M.4
Iyer, S.P.5
Fisch, D.C.6
-
23
-
-
33750633353
-
Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies
-
Burke B., Derby N.R., Kraft Z., Saunders C.J., Dai C., Llewellyn N., et al. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Virology 355 November (2) (2006) 138-151
-
(2006)
Virology
, vol.355
, Issue.November 2
, pp. 138-151
-
-
Burke, B.1
Derby, N.R.2
Kraft, Z.3
Saunders, C.J.4
Dai, C.5
Llewellyn, N.6
-
24
-
-
23844468382
-
Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope
-
Doria-Rose N.A., Learn G.H., Rodrigo A.G., Nickle D.C., Li F., Mahalanabis M., et al. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. J Virol 79 September (17) (2005) 11214-11224
-
(2005)
J Virol
, vol.79
, Issue.September 17
, pp. 11214-11224
-
-
Doria-Rose, N.A.1
Learn, G.H.2
Rodrigo, A.G.3
Nickle, D.C.4
Li, F.5
Mahalanabis, M.6
-
25
-
-
19944427052
-
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein
-
Gao F., Weaver E.A., Lu Z., Li Y., Liao H.X., Ma B., et al. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J Virol 79 January (2) (2005) 1154-1163
-
(2005)
J Virol
, vol.79
, Issue.January 2
, pp. 1154-1163
-
-
Gao, F.1
Weaver, E.A.2
Lu, Z.3
Li, Y.4
Liao, H.X.5
Ma, B.6
-
26
-
-
0030050009
-
Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
-
Richardson Jr. T.M., Stryjewski B.L., Broder C.C., Hoxie J.A., Mascola J.R., Earl P.L., et al. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. J Virol 70 February (2) (1996) 753-762
-
(1996)
J Virol
, vol.70
, Issue.February 2
, pp. 753-762
-
-
Richardson Jr., T.M.1
Stryjewski, B.L.2
Broder, C.C.3
Hoxie, J.A.4
Mascola, J.R.5
Earl, P.L.6
-
27
-
-
33751226889
-
Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes
-
Xu J., Ren L., Huang X., Qiu C., Liu Y., and Shao Y. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes. AIDS 20 November (18) (2006) 2293-2303
-
(2006)
AIDS
, vol.20
, Issue.November 18
, pp. 2293-2303
-
-
Xu, J.1
Ren, L.2
Huang, X.3
Qiu, C.4
Liu, Y.5
Shao, Y.6
-
28
-
-
0035155850
-
Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers
-
Yang X., Wyatt R., and Sodroski J. Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol 75 February (3) (2001) 1165-1171
-
(2001)
J Virol
, vol.75
, Issue.February 3
, pp. 1165-1171
-
-
Yang, X.1
Wyatt, R.2
Sodroski, J.3
-
29
-
-
34547154404
-
Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization
-
Zhang P.F., Cham F., Dong M., Choudhary A., Bouma P., Zhang Z., et al. Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. Proc Natl Acad Sci USA 104 June (24) (2007) 10193-10198
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, Issue.June 24
, pp. 10193-10198
-
-
Zhang, P.F.1
Cham, F.2
Dong, M.3
Choudhary, A.4
Bouma, P.5
Zhang, Z.6
-
30
-
-
0035922883
-
Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells
-
Meissner P., Pick H., Kulangara A., Chatellard P., Friedrich K., and Wurm F.M. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75 October (2) (2001) 197-203
-
(2001)
Biotechnol Bioeng
, vol.75
, Issue.October 2
, pp. 197-203
-
-
Meissner, P.1
Pick, H.2
Kulangara, A.3
Chatellard, P.4
Friedrich, K.5
Wurm, F.M.6
-
31
-
-
34147125994
-
Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives
-
Baldi L., Hacker D.L., Adam M., and Wurm F.M. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29 May (5) (2007) 677-684
-
(2007)
Biotechnol Lett
, vol.29
, Issue.May 5
, pp. 677-684
-
-
Baldi, L.1
Hacker, D.L.2
Adam, M.3
Wurm, F.M.4
-
32
-
-
38449121649
-
High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI
-
Backliwal G., Hildinger M., Hasija V., and Wurm F.M. High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI. Biotechnol Bioeng 99 February (3) (2008) 721-727
-
(2008)
Biotechnol Bioeng
, vol.99
, Issue.February 3
, pp. 721-727
-
-
Backliwal, G.1
Hildinger, M.2
Hasija, V.3
Wurm, F.M.4
-
33
-
-
33846049519
-
Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells
-
Carpentier E., Paris S., Kamen A.A., and Durocher Y. Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells. J Biotechnol 128 February (2) (2007) 268-280
-
(2007)
J Biotechnol
, vol.128
, Issue.February 2
, pp. 268-280
-
-
Carpentier, E.1
Paris, S.2
Kamen, A.A.3
Durocher, Y.4
-
34
-
-
51449106720
-
High-level expression and purification of a designed angiopoietin-1 chimeric protein. COMP-Ang1, produced in Chinese hamster ovary cells
-
Hwang S.J., Kim S.H., Kim H.Z., Steinmetz M.O., Koh G.Y., and Lee G.M. High-level expression and purification of a designed angiopoietin-1 chimeric protein. COMP-Ang1, produced in Chinese hamster ovary cells. Protein J 27 August (5) (2008) 319-326
-
(2008)
Protein J
, vol.27
, Issue.August 5
, pp. 319-326
-
-
Hwang, S.J.1
Kim, S.H.2
Kim, H.Z.3
Steinmetz, M.O.4
Koh, G.Y.5
Lee, G.M.6
-
35
-
-
46349100443
-
Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells
-
Liu C., Dalby B., Chen W., Kilzer J.M., and Chiou H.C. Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol Biotechnol 39 June (2) (2008) 141-153
-
(2008)
Mol Biotechnol
, vol.39
, Issue.June 2
, pp. 141-153
-
-
Liu, C.1
Dalby, B.2
Chen, W.3
Kilzer, J.M.4
Chiou, H.C.5
-
36
-
-
8344271026
-
Production of recombinant protein therapeutics in cultivated mammalian cells
-
Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22 November (11) (2004) 1393-1398
-
(2004)
Nat Biotechnol
, vol.22
, Issue.November 11
, pp. 1393-1398
-
-
Wurm, F.M.1
-
37
-
-
26444612689
-
Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production
-
Geisse S., and Henke M. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics 6 2-3 (2005) 165-170
-
(2005)
J Struct Funct Genomics
, vol.6
, Issue.2-3
, pp. 165-170
-
-
Geisse, S.1
Henke, M.2
-
38
-
-
0035689186
-
Effects of pCIneo and pCEP4 expression vectors on transient and stable protein production in human and simian cells lines
-
Parham J.H., Kost T., and Hutchins J.T. Effects of pCIneo and pCEP4 expression vectors on transient and stable protein production in human and simian cells lines. Cytotechnology 35 (2001) 181-187
-
(2001)
Cytotechnology
, vol.35
, pp. 181-187
-
-
Parham, J.H.1
Kost, T.2
Hutchins, J.T.3
-
39
-
-
0242642132
-
SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture
-
Schlaeger E.J., Kitas E.A., and Dorn A. SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture. Cytotechnology 42 May (1) (2003) 47-55
-
(2003)
Cytotechnology
, vol.42
, Issue.May 1
, pp. 47-55
-
-
Schlaeger, E.J.1
Kitas, E.A.2
Dorn, A.3
-
40
-
-
33745259524
-
Enhancement of transient gene expression by fed-batch culture of HEK 293 EBNA1 cells in suspension
-
Sun X., Goh P.E., Wong K.T., Mori T., and Yap M.G. Enhancement of transient gene expression by fed-batch culture of HEK 293 EBNA1 cells in suspension. Biotechnol Lett 28 June (11) (2006) 843-848
-
(2006)
Biotechnol Lett
, vol.28
, Issue.June 11
, pp. 843-848
-
-
Sun, X.1
Goh, P.E.2
Wong, K.T.3
Mori, T.4
Yap, M.G.5
-
41
-
-
34147180438
-
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry
-
Blish C.A., Nedellec R., Mandaliya K., Mosier D.E., and Overbaugh J. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry. AIDS 21 March (6) (2007) 693-702
-
(2007)
AIDS
, vol.21
, Issue.March 6
, pp. 693-702
-
-
Blish, C.A.1
Nedellec, R.2
Mandaliya, K.3
Mosier, D.E.4
Overbaugh, J.5
-
42
-
-
0012041487
-
Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus
-
Cheng-Mayer C., Weiss C., Seto D., and Levy J.A. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci USA 86 November (21) (1989) 8575-8579
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, Issue.November 21
, pp. 8575-8579
-
-
Cheng-Mayer, C.1
Weiss, C.2
Seto, D.3
Levy, J.A.4
-
43
-
-
0037082158
-
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
-
Durocher Y., Perret S., and Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30 January (2) (2002) E9
-
(2002)
Nucleic Acids Res
, vol.30
, Issue.January 2
-
-
Durocher, Y.1
Perret, S.2
Kamen, A.3
-
44
-
-
0344622126
-
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
-
Yates J., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81 June (12) (1984) 3806-3810
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, Issue.June 12
, pp. 3806-3810
-
-
Yates, J.1
Warren, N.2
Reisman, D.3
Sugden, B.4
-
45
-
-
0021988550
-
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
-
Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 February-March (6005) (1985) 812-815
-
(1985)
Nature
, vol.313
, Issue.February-March 6005
, pp. 812-815
-
-
Yates, J.L.1
Warren, N.2
Sugden, B.3
-
46
-
-
14244252530
-
Orbital shaker technology for the cultivation of mammalian cells in suspension
-
Muller N., Girard P., Hacker D.L., Jordan M., and Wurm F.M. Orbital shaker technology for the cultivation of mammalian cells in suspension. Biotechnol Bioeng 89 February (4) (2005) 400-406
-
(2005)
Biotechnol Bioeng
, vol.89
, Issue.February 4
, pp. 400-406
-
-
Muller, N.1
Girard, P.2
Hacker, D.L.3
Jordan, M.4
Wurm, F.M.5
-
47
-
-
50849109798
-
Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions
-
Backliwal G., Hildinger M., Chenuet S., Wulhfard S., De Jesus M., and Wurm F.M. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36 September (15) (2008) e96
-
(2008)
Nucleic Acids Res
, vol.36
, Issue.September 15
-
-
Backliwal, G.1
Hildinger, M.2
Chenuet, S.3
Wulhfard, S.4
De Jesus, M.5
Wurm, F.M.6
-
48
-
-
36348946963
-
Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses
-
Blay W.M., Kasprzyk T., Misher L., Richardson B.A., and Haigwood N.L. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. J Virol 81 December (23) (2007) 13037-13049
-
(2007)
J Virol
, vol.81
, Issue.December 23
, pp. 13037-13049
-
-
Blay, W.M.1
Kasprzyk, T.2
Misher, L.3
Richardson, B.A.4
Haigwood, N.L.5
-
49
-
-
34249952292
-
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
-
Kraft Z., Derby N.R., McCaffrey R.A., Niec R., Blay W.M., Haigwood N.L., et al. Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 81 June (12) (2007) 6402-6411
-
(2007)
J Virol
, vol.81
, Issue.June 12
, pp. 6402-6411
-
-
Kraft, Z.1
Derby, N.R.2
McCaffrey, R.A.3
Niec, R.4
Blay, W.M.5
Haigwood, N.L.6
-
50
-
-
58149487645
-
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather D.N., Armann J., Ching L.K., Mavrantoni A., Sellhorn G., Caldwell Z., et al. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J Virol 83 January (2) (2009) 757-769
-
(2009)
J Virol
, vol.83
, Issue.January 2
, pp. 757-769
-
-
Sather, D.N.1
Armann, J.2
Ching, L.K.3
Mavrantoni, A.4
Sellhorn, G.5
Caldwell, Z.6
-
51
-
-
33646867165
-
The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent
-
Kirschner M., Monrose V., Paluch M., Techodamrongsin N., Rethwilm A., and Moore J.P. The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent. Protein Expr Purif 48 July (1) (2006) 61-68
-
(2006)
Protein Expr Purif
, vol.48
, Issue.July 1
, pp. 61-68
-
-
Kirschner, M.1
Monrose, V.2
Paluch, M.3
Techodamrongsin, N.4
Rethwilm, A.5
Moore, J.P.6
-
52
-
-
38949090023
-
N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus
-
Dey A.K., David K.B., Ray N., Ketas T.J., Klasse P.J., Doms R.W., et al. N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus. Virology 372 March (1) (2008) 187-200
-
(2008)
Virology
, vol.372
, Issue.March 1
, pp. 187-200
-
-
Dey, A.K.1
David, K.B.2
Ray, N.3
Ketas, T.J.4
Klasse, P.J.5
Doms, R.W.6
-
53
-
-
33746796761
-
Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct
-
Kumar S., Yan J., Muthumani K., Ramanathan M.P., Yoon H., Pavlakis G.N., et al. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol 25 July (7) (2006) 383-392
-
(2006)
DNA Cell Biol
, vol.25
, Issue.July 7
, pp. 383-392
-
-
Kumar, S.1
Yan, J.2
Muthumani, K.3
Ramanathan, M.P.4
Yoon, H.5
Pavlakis, G.N.6
-
54
-
-
0141788494
-
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate
-
Srivastava I.K., Stamatatos L., Kan E., Vajdy M., Lian Y., Hilt S., et al. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. J Virol 77 October (20) (2003) 11244-11259
-
(2003)
J Virol
, vol.77
, Issue.October 20
, pp. 11244-11259
-
-
Srivastava, I.K.1
Stamatatos, L.2
Kan, E.3
Vajdy, M.4
Lian, Y.5
Hilt, S.6
-
55
-
-
33845935849
-
Large-scale transfection of mammalian cells for the fast production of recombinant protein
-
Pham P.L., Kamen A., and Durocher Y. Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol 34 October (2) (2006) 225-237
-
(2006)
Mol Biotechnol
, vol.34
, Issue.October 2
, pp. 225-237
-
-
Pham, P.L.1
Kamen, A.2
Durocher, Y.3
-
56
-
-
37549052183
-
High-density transient gene expression in suspension-adapted 293 EBNA1 cells
-
Sun X., Hia H.C., Goh P.E., and Yap M.G. High-density transient gene expression in suspension-adapted 293 EBNA1 cells. Biotechnol Bioeng 99 January (1) (2008) 108-116
-
(2008)
Biotechnol Bioeng
, vol.99
, Issue.January 1
, pp. 108-116
-
-
Sun, X.1
Hia, H.C.2
Goh, P.E.3
Yap, M.G.4
-
57
-
-
64349114245
-
Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells
-
Grillberger L., Kreil T.R., Nasr S., and Reiter M. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J 4 February (2) (2009) 186-201
-
(2009)
Biotechnol J
, vol.4
, Issue.February 2
, pp. 186-201
-
-
Grillberger, L.1
Kreil, T.R.2
Nasr, S.3
Reiter, M.4
-
58
-
-
52249107853
-
Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells
-
Loignon M., Perret S., Kelly J., Boulais D., Cass B., Bisson L., et al. Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol 8 (2008) 65
-
(2008)
BMC Biotechnol
, vol.8
, pp. 65
-
-
Loignon, M.1
Perret, S.2
Kelly, J.3
Boulais, D.4
Cass, B.5
Bisson, L.6
-
59
-
-
60349106556
-
Transient expression and purification of chimeric heavy chain antibodies
-
Zhang J., Liu X., Bell A., To R., Baral T.N., Azizi A., et al. Transient expression and purification of chimeric heavy chain antibodies. Protein Expr Purif 65 May (1) (2009) 77-82
-
(2009)
Protein Expr Purif
, vol.65
, Issue.May 1
, pp. 77-82
-
-
Zhang, J.1
Liu, X.2
Bell, A.3
To, R.4
Baral, T.N.5
Azizi, A.6
-
60
-
-
64949176720
-
Production of chimeric heavy-chain antibodies
-
xv
-
Zhang J., MacKenzie R., and Durocher Y. Production of chimeric heavy-chain antibodies. Methods Mol Biol 525 (2009) 323-336 xv
-
(2009)
Methods Mol Biol
, vol.525
, pp. 323-336
-
-
Zhang, J.1
MacKenzie, R.2
Durocher, Y.3
|